Office-use compounding in South Carolina

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

Four cumulative conditions, and not one is a scarcity gateHigh confidence

Who — physicians administering in an office or licensed ambulatory surgical facility setting. Source — ordered and purchased from the compounding pharmacy, which under (CC)(1) must be permitted in South Carolina. Use — stored in the office for future use, and not resold. Relationship — administered according to the usual physician/patient/pharmacy practice relationship. There is no emergency trigger, no commercial-unavailability test and no shortage predicate anywhere in the limb.

What the permission does not reachHigh confidence

It is a grant of South Carolina law and nothing more. Section 40-43-86 attaches no federal-compliance condition, incorporates no federal compounding provision, and cannot displace one. The defensible sentence always names South Carolina law; the unqualified version reads as a federal claim and is not one.This is the same shape as Texas and the opposite of North Carolina. A state that declines to route through federal law has granted more, not less — and has therefore left the federal question entirely untouched rather than answered.

The permission is not portable, and this is the easiest condition to missHigh confidence

Subsection (CC)(1) opens the whole subsection with a licensure gate: its provisions apply only to compounding by pharmacies permitted in South Carolina. A pharmacy outside the state that does not hold that permit falls outside (CC) altogether, and therefore outside the office-use limb with it. The permission attaches to the supplier’s credential rather than to the physician’s location.

Sterile and non-sterileHigh confidence

Subsection (CC)(2)(h) draws no distinction between them. The institutional limb immediately below it, (CC)(2)(i), is express on the point — institutional pharmacies may order and store compounded preparations "both sterile and nonsterile" in anticipation of patient orders, with a chart order required before administration in an institutional facility.Note the asymmetry between the two limbs: the institutional one requires a chart order at the point of administration and the physician-office one does not. They are adjacent sentences and they are not the same rule.

Quantity — a historical-prescribing test, not a percentageHigh confidence

The only ceiling is qualitative. Under (CC)(2)(g), compounding in anticipation of prescriptions "without a historical basis", or distributing compounded preparations without a patient/practitioner/pharmacist relationship, is manufacturing — which is a different regulatory category with a different credential attached.

Label legendHigh confidence

None exists for the human limb. The words "but not for resale" in (CC)(2)(h) restrict what the physician may do with the stock; they are not a legend the container must carry. No South Carolina provision prescribes office-use label wording for human preparations.

The veterinary limb, and the only number in South Carolina compounding lawHigh confidence

S.C. Code Regs. R.99-47, effective June 26, 2020, lets a pharmacist compound veterinary preparations for veterinarians to use in their offices for administration to animals; onward supply to an owner is confined to an urgent or emergency situation for a single course of treatment "not to exceed a 168-hour supply". That cap is the only numeric limit anywhere in the state’s compounding law, and it does not touch human office stock.R.99-47 is also the only place South Carolina uses the literal phrase "office use", which is why a keyword search of the state’s law lands on the animal rule and misses the human permission entirely.

The Medical Practice Act says nothing about thisHigh confidence

Title 40, Chapter 47 contains no compounding or office-use provision — verified by searching the chapter. The answer lives entirely in the Pharmacy Practice Act, so a reader who checks the physician licensing statute finds nothing and may conclude, wrongly, that the question is unaddressed.

The 5% clause, and it is double-gated hereHigh confidence

South Carolina’s analogue is not a bare threshold: it is confined to "emergency medical reasons" and to alleviating "a temporary shortage". A standing supply arrangement is neither. It is in any event an exemption from wholesale-distributor licensure measured on the seller, and it authorises no compounding — which matters less here than elsewhere, because § 40-43-86(CC)(2)(h) authorises the supply directly and carries no scarcity condition at all.Reaching the right answer through the shortage exemption would import a gate the governing subsection does not contain. Right answer, wrong route.

Entity or person — the split is the findingMedium confidence

Section 40-43-30(43) defines "person" to include corporations and other legal entities, but the possession-and-administration exemption at § 40-43-60(H) runs to "a licensed practitioner", and § 40-43-86(CC)(2)(h) says "Physicians who administer". The one express entity limb, § 40-43-60(I), covers dispensing rather than office-use administration and is conditioned on the entity being "fully owned by licensed practitioners".Practically: a physician-owned professional corporation is squarely inside (I)’s ownership test, while an entity with any non-practitioner ownership is not, and whether (I)’s limit reads across to possessing and administering under (H) — which has no entity clause at all — is unresolved. No board opinion was found either way.

Last changeHigh confidence

Section 40-43-86 has not been amended since 2024 Act No. 132, effective May 13, 2024. The office-use limb survived a full rewrite of the section unchanged. The regulations moved more recently: Doc. No. 5422, effective May 22, 2026, rewrote R.99-43(D).A Notice of Drafting for Chapter 99 was published June 26, 2026 (S.C. State Register Vol. 50 Iss. 6) covering, among other things, compounding. No text exists yet. A regulation cannot repeal a statutory permission, but it can condition practice around it — recordkeeping, beyond-use dating, labelling or volume.

South Carolina at a glance

Receiving 503B office stock in South Carolina

South Carolina licenses outsourcing facilities through the Board of Pharmacy inside the Department of Labour, Licensing and Regulation, and the rules governing them were rewritten effective 22 May 2026. Advice written before that date is now wrong in three places, and one of the changes puts a duty on the buyer rather than the shipper.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What South Carolina asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

An Outsourcing Facility (503B) Permit from the S.C. Board of Pharmacy. As rewritten by Doc. No. 5422, R.99-43(D)(1) requires the permit of a facility compounding at one geographic location that wishes to sell, dispense, transfer or distribute non-patient-specific compounded products in the state, and requires that facility to register with FDA as a 503B outsourcing facility. The fee schedule carries both a resident category at $280 new and $140 renewal and a non-resident category at $700 either way.Three things changed on 22 May 2026 and stale advice now misstates all of them. The word "sterile" was struck, so the permit triggers on any non-patient-specific compounded product rather than only sterile ones. The old blanket requirement to hold a South Carolina pharmacy permit as well survives only for facilities dispensing patient-specific prescriptions, under (D)(1)(b). And a named, actively South Carolina-licensed pharmacist-in-charge is now mandatory under (D)(2)(b), with changes reported within 30 days.

Does your practice need a permit?Medium confidence

On the statute, no: § 40-43-60(H) provides that nothing in the chapter requires a permit of, or prevents, a licensed practitioner possessing or administering drugs in the regular course of professional practice. A regulation cuts against that for some structures — R.99-43(F)(1) requires a Non-Dispensing Drug Outlet Permit of facilities that store or administer legend drugs, and names "public or private health clinics" in its non-exhaustive list. That permit requires a consultant pharmacist.A conventional physician practice should be exempt, and a regulation cannot override a statute. But the line between a licensed practitioner in the regular course of practice and a "private health clinic" is undrawn, and a med spa, IV clinic or weight-management clinic structured as a facility rather than as a physician’s practice sits squarely in the grey zone — with a consultant pharmacist attached if it lands on the wrong side. No board advisory resolves it. This is the South Carolina question most readers actually have.

Administer vs dispenseMedium confidence

Section 40-43-60(H) exempts possessing and administering. Dispensing is where the entity question bites: § 40-43-60(I) permits a practitioner to dispense drugs that are the lawful property of the practitioner or of a partnership or corporate entity "fully owned by licensed practitioners". An investor-owned clinic has no equivalent limb, and the office-use limb itself authorises administration only — the stock is stored "for future use but not for resale".

Scheduled (controlled) stockHigh confidence

A separate state registration is required and it comes BEFORE the federal one. Section 44-53-290(a) requires every person who manufactures, distributes or dispenses a controlled substance to register with the department, and § 44-53-290(e) requires a separate registration at each principal place of business or professional practice. The registrar is the S.C. Department of Public Health, Bureau of Drug Control, renamed from DHEC by 2026 Act No. 146, signed 15 May 2026 — any page still naming DHEC is out of date.The sequencing is counterintuitive and the department states it: obtain the South Carolina registration first, then align the federal registration address, because the two addresses must match. For a non-resident outsourcing facility the order runs board permit, then state controlled-substance registration, then federal address alignment. Most compounded office-use preparations in this vertical are legend drugs rather than scheduled substances, so this often sits outside the path entirely.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• The Board of Pharmacy’s "Working Draft of Compounding Regulations, August 2026" could not be retrieved: the board’s site is a JavaScript application that served no document links to a direct fetch. It is the document most likely to add conditions on top of the statutory permission, and we have not seen it — treat it as the largest open item on this page.
• The Sterile and Non-Sterile Compounding Pharmacy Inspection Forms in use on 2 July 2024 are incorporated by reference as the binding interim standard by § 40-43-86(CC)(2)(a)(iii) and R.99-43. We have not fetched them, and they could carry office-use conditions that are invisible in the statute.
• Whether a physician office in practice takes a Non-Dispensing Drug Outlet Permit is unresolved. The statute says no, R.99-43(F) creates real tension, and we found no board advisory. Med-spa and IV-clinic structures are the ones this turns on.
• We searched no case law, attorney-general opinions, board newsletters, declaratory rulings or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.